From Table it is clear

From Table 1, it is clear that a higher proportion of coeliac disease was found among females in the middle age group of 20–39years. 38% of all detected with coeliac disease in the same age group were females compared to 16% of males. In the age group of 40–59years, the prevalence of coeliac disease was found higher among males, – 25% compared to 20% among females.
Of the 55 cases diagnosed in the course of this study, the repercussions of undetected or latent coeliac disease were calculated thus: Underweight patients constituted 72.7%; those detected with iron deficiency anaemia were 34.5% of the 55 cases, those with vitamin D insufficiency had reached 67.3%. Also, osteoporosis and dermatitis carriers in the group were 61.8% and 7.3%, respectively (Table 2, Fig. 1).

Discussion
The study in essence, gives an approximation of the preponderance of serological markers coupled with biopsy-authenticated coeliac disease with respect to a person carrying irritable bowel syndrome, (IBS). In the same vein, the study clearly delineates the prevalence of coeliac disease in adults that have not been detected despite the fact that there are limited data on coeliac disease in Saudi Arabia. The lorcaserin hydrochloride of positive serological results with biopsy-proven coeliac disease was 1.9% in the control undetected group, while the same procedure for the irritable bowel syndrome (IBS) patients with coeliac disease was 9.6%. We need to note here that the current results are in virtual agreement with our previous study (Al-Ajlan, 2013).
In many countries of western hemisphere, it is estimated that about 1% of the populace are indeed carrying coeliac disease and studies have shown that in the west, the upsurge grows correspondingly with the ageing of the population (Mustalahti et al., 2010). In Scotland, according to recent studies, the incidence of paediatric coeliac disease increased 6.4-fold over 20years (White et al., 2013). Furthermore, in Finland, according to one report, the incidence of coeliac disease was 1.5% among children (Mäki et al., 2003), 2% in adults and 2.7% in the elderly (Vilppula et al., 2009). In the United States, the prevalence among the populace is about 1% (Alberto et al., 2012). As a result of the serological studies carried out in Australasia, Europe and South America, between 0.5 and 1% of the people in these countries carry the disease undetected (West et al., 2003; Fasano et al., 2003). The implications of identifying latent coeliac disease among the populace are not clear as there is a paucity of reported data arising from few selected cases as regards death and other psychological features earlier noticed in the latent coeliac disease.
Furthermore, only few research studies have succeeded in analyzing the welter of socio-demographic underpinnings with respect to the disease largely due to low size of the available sample. Among adults of the general populace, screenings have captured only a few number of hitherto undiagnosed cases. As a result, such studies are unable to clearly examine any linkage in comparison to the people in general (Mustalahti et al., 1999). In fact, the density of bone mineral and anthropometric measurement have been the main focal points of the earlier studies that seek to know the differences between clinically diagnosed coeliac disease and the undetected ones. Such studies delineate that people with latent coeliac disease tend to have insignificant levels of low bone density and measurements in line with harmless subnormal nutritional level (Scott et al., 2000). A study carried out on a cohort in Cambridge, UK, indicates that negative health effect such as mild anaemia arises from latent coeliac disease and osteoporosis. Interestingly, the study implicitly shows a diminished danger of cardiovascular ailment going by the observation of lower blood pressure, mass body index and lower serum cholesterol among persons carrying the latent coeliac disease. Of course, given the potent consequences of these results, there is a need to undertake an epidemiological assessment to ascertain it.